Oraya Therapeutics Receives $25,132,051 New Financing Round

  • Feed Type
  • Date
  • Company Name
    Oraya Therapeutics
  • Mailing Address
    8000 Jarvis Ave Newark, CA 94560 USA
  • Company Description
    Founded in 2006, Oraya’s first commercial application, the IRay system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy